Methods for treating skin infection by administering an IL-4R antagonist
US11603408B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | May 28, 2019 |
| Grant date | Mar 14, 2023 |
| Priority date | — |
| Expiry date | Aug 18, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating, preventing or ameliorating skin infections, including bacterial and viral infections. In certain embodiments, the invention provides methods to reduce skin infection in a patient with atopic dermatitis (AD). Also provided are methods for improving skin barrier function, and methods for reducing the risk of inflammation due to microbial infection in a patient in need thereof. The methods of the present invention comprise administering to a patient in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.